Evidence Review
World J Diabetes
13(6):422-433.
Published online Jun 15, 2022.
doi: 10.4239/wjd.v13.i6.422
Abstract (500)
|
Core Tip (527)
|
Full Article (HTML) (2971)
|
Tables (1-4) (396)
|
Full Article (PDF)-727K (316)
|
Audio-1990K (3)
|
Peer-Review Report-250K (91)
|
Answering Reviewers-101K (80)
|
Received: 12/20/2021
|
Revised: 05/01/2022
|
Accepted: 05/23/2022
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (6943)
|
Similar Articles (221)
|
Timeline of Article Publication (0)
|
Authors Evaluation (1)
|
Article Quality Tracking (4)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Investigating the specificity of endothelin-traps as a potential therapeutic tool for endothelin-1 related disorders
World J Diabetes
13(6):434-441.
Published online Jun 15, 2022.
doi: 10.4239/wjd.v13.i6.434
Abstract (361)
|
Core Tip (412)
|
Article Highlights (523)
|
Full Article (HTML) (1920)
|
Figures (1-3) (296)
|
Full Article (PDF)-850K (228)
|
Audio-285K (2)
|
Peer-Review Report-401K (101)
|
Answering Reviewers-153K (90)
|
Received: 01/27/2022
|
Revised: 04/24/2022
|
Accepted: 05/28/2022
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (6197)
|
Similar Articles (4)
|
Timeline of Article Publication (2)
|
Authors Evaluation (2)
|
Article Quality Tracking (3)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Diabetes
13(6):442-453.
Published online Jun 15, 2022.
doi: 10.4239/wjd.v13.i6.442
Abstract (440)
|
Core Tip (466)
|
Article Highlights (483)
|
Full Article (HTML) (2321)
|
Figures (1-8) (272)
|
Full Article (PDF)-5732K (240)
|
Audio-276K (3)
|
Peer-Review Report-533K (87)
|
Answering Reviewers-58K (88)
|
Received: 03/01/2022
|
Revised: 04/25/2022
|
Accepted: 05/23/2022
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (6693)
|
Similar Articles (20)
|
Timeline of Article Publication (2)
|
Authors Evaluation (1)
|
Article Quality Tracking (3)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Study
Immediate-release tofacitinib reduces insulin resistance in non-diabetic active rheumatoid arthritis patients: A single-center retrospective study
World J Diabetes
13(6):454-465.
Published online Jun 15, 2022.
doi: 10.4239/wjd.v13.i6.454
Abstract (345)
|
Core Tip (509)
|
Article Highlights (555)
|
Full Article (HTML) (1633)
|
Figures (1-3) (309)
|
Tables (1-3) (266)
|
Full Article (PDF)-1761K (209)
|
Audio-343K (0)
|
Peer-Review Report-225K (76)
|
Answering Reviewers-124K (63)
|
Received: 01/14/2022
|
Revised: 04/18/2022
|
Accepted: 05/28/2022
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (6511)
|
Similar Articles (136)
|
Timeline of Article Publication (0)
|
Authors Evaluation (1)
|
Article Quality Tracking (3)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letter to the Editor
World J Diabetes
13(6):466-470.
Published online Jun 15, 2022.
doi: 10.4239/wjd.v13.i6.466
Abstract (407)
|
Core Tip (447)
|
Full Article (HTML) (2043)
|
Tables (1-1) (246)
|
Full Article (PDF)-641K (299)
|
Audio-743K (0)
|
Peer-Review Report-179K (68)
|
Answering Reviewers-121K (53)
|
Received: 03/07/2022
|
Revised: 04/19/2022
|
Accepted: 05/23/2022
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (5283)
|
Similar Articles (1)
|
Timeline of Article Publication (5)
|
Authors Evaluation (1)
|
Article Quality Tracking (4)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open